-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Vincerx Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2019 to Q3 2024.
- Vincerx Pharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$7.79M, a 18.9% increase year-over-year.
- Vincerx Pharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$28.2M, a 43.8% increase year-over-year.
- Vincerx Pharma, Inc. annual Operating Income (Loss) for 2023 was -$42.6M, a 40.1% increase from 2022.
- Vincerx Pharma, Inc. annual Operating Income (Loss) for 2022 was -$71.2M, a 13.6% decline from 2021.
- Vincerx Pharma, Inc. annual Operating Income (Loss) for 2021 was -$62.7M, a 485% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)